anonymous
Guest
anonymous
Guest
Dying at $1.4 billion? Move on troll
DYING with better drug Eylea from Regeneron and the biggest threat of all the diluted Avastin to boot. Just wait till Avastin comes off patent in 2019 with slew of Avastin biosimilars from small and big pharmas.
PS - The Lucentis implant project is 3 yrs behind schedule and finally reached Ph II FPI milestone in late 2015 but reported to have stopped patient enrollment due to unexpected high "complications", gasp, why in the hell would any people sign up as guinea pig of their own eyeballs?